Portfolio company
Interax
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a computational pharmacology platform to design and optimise drug candidates targeting G-protein-coupled receptors for biopharmaceutical partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Skape.Bio
The company develops AI-designed biologic medicines targeting G protein-coupled receptors for the pharmaceutical industry.
ALLOX
This company develops a computational and experimental platform to identify allosteric sites in proteins for pharmaceutical companies and researchers to design new drugs.
Interlinetx
This company develops a precision medicine platform to map protein communities and discover small molecule drugs for patients with inflammatory diseases and cancer.
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
MendelFOLD
This company develops computational protein modelling tools to help pharmaceutical teams and researchers identify drug binding sites and design new medical treatments.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
GraphTX
The company develops a platform for precision drug discovery by mapping live patient immune cell behaviour to identify therapeutic targets for inflammatory diseases.
Pepper Bio
This company develops transomics software to identify biological targets and drug candidates for pharmaceutical and biotechnology researchers.
